Sutro Biopharma (STRO) PT Raised to $16 at Piper Sandler
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $20.48 -3.89%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff raised the price target on Sutro Biopharma (NASDAQ: STRO) to $16.00 (from $14.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sutro Biopharma (STRO) PT Lowered to $34 at Citizens on Q2 Revenue Miss
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
